Ventas - News Releases

December 22 - Ventas Receives Additional $50 Million Revolver Commitment; Company Increases Total Revolving Credit Capacity to $1.0 Billion
December 4 - Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share
December 3 - Ventas Completes Acquisition of Three Medical Office Buildings for $62.5 Million; Transaction Expands Company's MOB Portfolio to Over 1.6 Million Square Feet
November 24 - Ventas to Present at the Bank of America Merrill Lynch 2009 Credit Conference
November 24 - Ventas to Participate in the UBS 2009 Global Real Estate Conference
November 17 - Ventas Prevails Against HCP Post-Trial Motions
November 9 - Ventas CEO Named Chair of NAREIT
October 29 - Ventas Reports Third Quarter Normalized FFO of $0.66 Per Diluted Share; Ventas Increases 2009 Normalized FFO Per Diluted Share Guidance to $2.62 to $2.65
October 1 - Ventas Announces 2009 Third Quarter Earnings Release Date and Conference Call
October 1 - Ventas Appoints James L. Andrews VP, Hospital Business Development; Andrews to Expand Ventas’s Investments in Hospitals and Health Systems
September 28 - Ventas to Participate in the 2009 Bank of America Merrill Lynch Global Real Estate Conference
September 4 - Ventas to Participate in the BMO Capital Markets 2009 North American Real Estate Conference
September 4 - Ventas Prevails in Litigation Against HCP, Inc.; Ventas Awarded Over $101 Million in Damages
August 31 - Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share
July 30 - Ventas Reports Second Quarter Normalized FFO of $0.68 Per Diluted Share; Ventas Continues to Raise Attractive Long-Term Capital, Build Liquidity and Increase Cash Flow; Ventas Increases 2009 Normalized FFO Per Diluted Share Guidance to $2.55 to $2.62
July 16 - Ventas Comments on Court's Decision to Permit Its Case Against HCP To Go to Trial; Ventas Case to be Heard at a Jury Trial Scheduled for August 18, 2009 in the United States Federal Court for the Western District of Kentucky
July 9 - Ventas Announces 2009 Second Quarter Earnings Release Date and Conference Call
July 1 - Ventas Completes Sale of Six Underperforming Assets to Kindred Healthcare; Ventas to Record Gain Exceeding $35 Million
May 28 - Ventas to Present at the NAREIT REITWeek 2009 Conference
May 7 - Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share; Stockholders Re-elect Directors and Ratify E&Y; Board Re-appoints Leadership
May 5 - Ventas Reports First Quarter Normalized FFO of $0.67 Per Diluted Share; Ventas Continues to Build Liquidity and Financial Strength with Multiple Capital Markets Transactions; Successful Equity Raise and Debt Offering Result in 2009 Normalized FFO Guidance of $2.48 to $2.58 Per Diluted Common Share
May 4 - Ventas Announces Final Tender Offer Results
April 30 - Ventas Announces Extension of Lease Term for 109 Healthcare Assets until 2015; $127.1 Million of Annual Base Rent Renewed By Kindred; Ventas to Sell Six Underperforming Skilled Nursing Facilities to Kindred
April 20 - Ventas Announces Early Tender Results; Company to Offer Early Tender Premium for All Senior Notes Due 2012 Tendered Prior to Expiration Date
April 13 - Ventas Announces Satisfaction of Financing Condition in Tender Offers for Senior Notes
April 9 - Ventas Announces 2009 First Quarter Earnings Release Date and Conference Call
April 7 - Ventas Announces Pricing of Common Stock and Senior Notes Offerings
April 6 - Ventas Announces Tender Offers for Senior Notes
April 6 - Ventas Confirms Operating Financial Guidance for 2009
April 6 - Ventas Announces Public Offerings of Common Stock and Senior Notes
March 31 - Ventas Extends Its Revolving Credit Facilities to 2012; Company Increases Total Revolving Credit Capacity to $867 million
March 25 - Ventas Prevails Against HCP Counterclaims; Ventas Lawsuit Against HCP Set for August 2009 Jury Trial in Kentucky Federal Court
February 23 - Ventas to Present at the Citi 2009 Global Property CEO Conference
February 20 - Ventas Closes $35 Million Sale of Samaritan Hospital
February 12 - Ventas Reports Fourth Quarter Normalized FFO of $0.66 Per Diluted Share; 2008 Normalized FFO Per Diluted Share Increases Two Percent to $2.74 Versus Prior Year; Ventas Issues 2009 Normalized FFO Guidance of $2.55 to 2.65 Per Diluted Share; Dividend of $0.5125 Per Share Declared for First Quarter 2009
January 14 - Ventas Announces 2008 Fourth Quarter and Year-End Earnings Release Date and Conference Call
January 8 - Ventas Closes on Sale of Four Seniors Housing Assets to Benchmark